Business Description
Compare
Compare
Traded in other countries / regions
19T.GermanyIDIA.Switzerland0RQE.UKIDRSF.USA IPO Date
2017-07-13Description
Idorsia Ltd is a biopharmaceutical company engaged in discovering, developing, and commercializing of medicines for unmet medical needs. It is a biotech hub of Europe specialized in the discovery and development of small molecules, to provide innovative therapeutic options. The company focuses on multiple therapeutic areas which include the central nervous system, cardiovascular disorders, immunological disorders, and orphan diseases. Idorsia's development compounds target a number of different diseases such as Resistant Hypertension, lupus, insomnia, Cerebral vasospasm, and Fabry disease. Geographically, it derives revenue from Switzerland.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.39 | |||||
| Equity-to-Asset | -0.73 | |||||
| Debt-to-Equity | -1.86 | |||||
| Debt-to-EBITDA | -1.59 | |||||
| Piotroski F-Score | 1/9 | |||||
| Altman Z-Score | -5.82 | |||||
| Beneish M-Score | -1.31 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 43.8 | |||||
| 3-Year EBITDA Growth Rate | -7.7 | |||||
| 3-Year EPS without NRI Growth Rate | -7 | |||||
| 3-Year FCF Growth Rate | -10.4 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 17.22 | |||||
| 9-Day RSI | 29.34 | |||||
| 14-Day RSI | 33.96 | |||||
| 6-1 Month Momentum % | -7.75 | |||||
| 12-1 Month Momentum % | -29.06 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.5 | |||||
| Quick Ratio | 3.29 | |||||
| Cash Ratio | 2.8 | |||||
| Days Inventory | 1426.09 | |||||
| Days Sales Outstanding | 78.74 | |||||
| Days Payable | 1611.33 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -10.1 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 94.84 | |||||
| Operating Margin % | -826.93 | |||||
| Net Margin % | -852.6 | |||||
| ROA % | -72.27 | |||||
| ROIC % | -188.85 | |||||
| ROC (Joel Greenblatt) % | -353.58 | |||||
| ROCE % | -81.59 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 21.33 | |||||
| EV-to-EBIT | -3.66 | |||||
| EV-to-Forward-EBIT | -3.86 | |||||
| EV-to-EBITDA | -3.81 | |||||
| EV-to-Forward-EBITDA | -4.59 | |||||
| EV-to-Revenue | 30.28 | |||||
| EV-to-Forward-Revenue | 11.56 | |||||
| EV-to-FCF | -3.32 | |||||
| Earnings Yield (Greenblatt) % | -27.32 |
How Idorsia Ltd (IDRSF) Makes Its Money
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:IDRSF
Peter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
Executives
Details
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 102.561 | ||
| EPS (TTM) ($) | -4.906 | ||
| Beta | 0.6 | ||
| Volatility % | 55.38 | ||
| 14-Day RSI | 33.96 | ||
| 14-Day ATR ($) | 0.271026 | ||
| 20-Day SMA ($) | 12.9705 | ||
| 12-1 Month Momentum % | -29.06 | ||
| 52-Week Range ($) | 11.62 - 21.3425 | ||
| Shares Outstanding (Mil) | 187.56 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Idorsia Ltd Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Idorsia Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Idorsia Ltd Frequently Asked Questions
What is Idorsia Ltd(IDRSF)'s stock price today?
The current price of IDRSF is $12.50. The 52 week high of IDRSF is $21.34 and 52 week low is $11.62.
When is next earnings date of Idorsia Ltd(IDRSF)?
The next earnings date of Idorsia Ltd(IDRSF) is .
Does Idorsia Ltd(IDRSF) pay dividends? If so, how much?
Idorsia Ltd(IDRSF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
